Is Compass Pathways Stock a Buy?
Despite having an IPO just three months ago, Compass Pathways (NASDAQ: CMPS) is already up a staggering 224% from its IPO price of $17. If you invested $10,000 in its first-ever public offering, that investment would be worth over $32,400 today, far outperforming the S&P 500's 11.3% gain during the same period.
Despite being a small fish in the biotech ocean, Compass Pathways has the backing of billionaire tech-investor Peter Thiel with a 10 million euro stake. Just what could spark so much interest in an early-stage company with only one pipeline candidate?
Image source: Getty Images.
Source Fool.com


